Hyaluronan Receptor for Endocytosis (HARE), encoded by the STAB2 gene, is a multifaceted protein integral to the endocytic pathway of cells, particularly within the liver and spleen. It functions primarily in the clearance and recycling of glycosaminoglycans (GAGs) like hyaluronan, heparin, and dermatan sulfate from the circulatory system, maintaining extracellular matrix homeostasis. HARE's role extends beyond GAGs clearance, as it also contributes to the uptake of various ligands linked to inflammation and nutrient delivery, highlighting its significance in maintaining cellular and systemic equilibrium. The expression of HARE is a tightly regulated process, sensitive to a range of intracellular signaling pathways and external stimuli, ensuring its activity is appropriately modulated in response to physiological demands. Given its central role in cellular clearance mechanisms, understanding the factors that can downregulate HARE expression is of considerable interest in the context of cellular biology and homeostasis.
Several chemical compounds have been identified that could potentially inhibit the expression of HARE by targeting different stages of gene expression and protein synthesis. Compounds such as Trichostatin A and 5-Azacytidine may downregulate HARE by altering the chromatin structure around the STAB2 gene or by affecting DNA methylation patterns, respectively. Meanwhile, translation-focused inhibitors like Rapamycin and Cycloheximide could decrease HARE protein synthesis through the inhibition of the mTOR signaling pathway or by blocking the translocation step in protein elongation. Other compounds, including Actinomycin D and Spliceostatin A, might directly hinder the transcriptional activity of the STAB2 gene or alter mRNA splicing, leading to reduced levels of functional HARE protein. Additionally, the use of proteasome inhibitors such as MG132 could indirectly lower HARE expression by triggering a cellular stress response that suppresses the transcription of various genes. The interplay between these compounds and HARE expression embodies the complexity of cellular regulation and the fine-tuning required to maintain physiological balance. Understanding the nuanced effects of these inhibitors on HARE offers valuable insights into the sophisticated orchestration of cellular functions and the potential for chemical biology to unravel these intricate processes.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This histone deacetylase inhibitor may alter chromatin structure and potentially downregulate STAB2 gene transcription, thereby reducing HARE protein levels. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, it might change the methylation status of the STAB2 gene promoter, indirectly affecting HARE expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
This mTOR inhibitor can affect protein synthesis pathways, potentially decreasing the translation of many proteins, including HARE. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
By binding to DNA, it may inhibit RNA polymerase and thus block the transcription of the STAB2 gene, reducing HARE protein synthesis. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
This compound inhibits eukaryotic protein synthesis by interfering with the translocation step in protein elongation, which could reduce HARE levels. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
As a regulator of gene expression, it could modulate the transcription of a subset of genes, potentially including STAB2, affecting HARE protein levels. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
By raising endosomal pH, it could interfere with the endocytosis process that HARE is involved in, indirectly affecting its expression or recycling. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
This compound disrupts the Golgi apparatus, possibly impacting the trafficking of membrane proteins like HARE and affecting its expression on the cell surface. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
As a proteasome inhibitor, MG-132 can increase the half-life of proteins, but it may also lead to reduced transcription of certain genes, possibly including STAB2. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
By affecting mRNA splicing, it might alter the maturation of STAB2 mRNA transcripts, potentially reducing functional HARE protein expression. | ||||||